2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Lymphoma, Non-Hodgkin
4
Leukemia, Myeloid, Acute
4
Leukemia
4
Colonic Neoplasms
4
Congenital Abnormalities
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Waldenstrom Macroglobulinemia
2
Somatostatinoma
2
Recurrence
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Neoplasms
2
Myeloproliferative Disorders
2
Multiple Myeloma
2
Melanoma
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lymphoma
2
Lung Neoplasms
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Monocytic, Acute
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Erythroblastic, Acute
2
Colorectal Neoplasms
2
Carcinoma, Islet Cell
2
Vulvar Neoplasms
1
Vipoma
1
Vaginal Neoplasms
1
Interventions
Temozolomide
115
Radiotherapy
63
Magnetic Resonance Spectroscopy
30
Carboplatin
30
Bevacizumab
30
Carmustine
28
Filgrastim
23
Surgical Procedures, Operative
22
Irinotecan
22
Radiation
18
Lomustine
17
Vincristine
15
Etoposide
15
Specimen Handling
13
Peripheral Blood Stem Cell Transplantation
13
O(6)-benzylguanine
13
Radiotherapy, Intensity-Modulated
12
Procarbazine
11
Erlotinib Hydrochloride
11
Cyclophosphamide
11
Chemotherapy, Adjuvant
11
sargramostim
10
Thiotepa
10
Cisplatin
10
Flucytosine
9
Everolimus
9
antineoplaston AS 2-1
8
antineoplaston A10
8
Granulocyte Colony-Stimulating Factor
8
Vorinostat
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Astrocytoma
×
Biological Therapy
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled